4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,354 | -32,401 | -100,837 | -68,554 | -58,298 |
| Depreciation Amortization | -725 | 416 | 2,960 | 2,337 | 1,493 |
| Accounts payable and accrued liabilities | -83 | 703 | 896 | 1,984 | 614 |
| Other Working Capital | -4,208 | -3,520 | 630 | -34 | -3,132 |
| Other Operating Activity | 13,039 | 5,714 | 20,559 | 13,125 | 9,352 |
| Operating Cash Flow | $-59,331 | $-29,088 | $-75,792 | $-51,142 | $-49,971 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,059 | -710 | -2,771 | -2,222 | -1,817 |
| Purchase Of Investment | -374,084 | -277,324 | -54,802 | -20,156 | -20,156 |
| Sale Of Investment | 38,346 | 14,776 | 173,290 | 144,777 | 114,391 |
| Investing Cash Flow | $-336,797 | $-263,258 | $115,717 | $122,399 | $92,418 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 336,081 | 318,832 | 156,832 | 152,070 | 142,054 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -541 |
| Financing Cash Flow | $336,081 | $318,832 | $156,832 | $152,070 | $141,513 |
| Beginning Cash Position | 249,108 | 249,108 | 52,351 | 52,351 | 52,351 |
| End Cash Position | 189,061 | 275,594 | 249,108 | 275,678 | 236,311 |
| Net Cash Flow | $-60,047 | $26,486 | $196,757 | $223,327 | $183,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,331 | -29,088 | -75,792 | -51,142 | -49,971 |
| Capital Expenditure | -1,059 | -710 | -2,771 | -2,222 | -1,817 |
| Free Cash Flow | -60,390 | -29,798 | -78,563 | -53,364 | -51,788 |